| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/07/2009 | US20090118184 Recombinant factor viii having increased stability |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118181 Compositions and methods for producing bioactive fusion proteins |
| 05/07/2009 | US20090117618 Expression system for preparing IL-15/FC fusion protein and its use |
| 05/07/2009 | US20090117617 Methods and compositions for targeted integration |
| 05/07/2009 | US20090117616 Methods for reducing or eliminating alpha-mannosidase resistant glycans for the production of glycoproteins |
| 05/07/2009 | US20090117615 Recombinant mammal cells, method of producing thereof, and method of producing proteins of interest |
| 05/07/2009 | US20090117614 degrading mannans and polysaccharides in plant material thus providing a means to recover soluble sugars from these biopolymers |
| 05/07/2009 | US20090117609 in vivo labeling and identifying recombinantly produced peptides or proteins within an unpermeabilized prokaryotic host cell; comprise at least one tetracysteine tag are labeled in vivo with a biarsenical labeling reagent that binds to the tetracysteine tag and forms a detectable fluorescent complex |
| 05/07/2009 | US20090117590 Human calcium sensitive potassium channel beta3 subunit proteins, encoding nucleic acid and uses thereof |
| 05/07/2009 | US20090117581 in vitro comprising preparing a cell culture comprising dendritic cells primed with an antigen, then adding syngeneic and allogeneic lymphocytes to the cell culture and measuring the lymphocyte response to the antigen and comparing the response control culture in which the antigen was not used |
| 05/07/2009 | US20090117580 Structure of prl-1 protein crystal and the method of crystallization thereof |
| 05/07/2009 | US20090117566 Compositions and methods for the diagnosis and treatment of tumor |
| 05/07/2009 | US20090117564 Estrogen receptor genes and utilization thereof |
| 05/07/2009 | US20090117538 Methods for Obtaining Gene Tags |
| 05/07/2009 | US20090117143 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens |
| 05/07/2009 | US20090117136 Recombinant allergen |
| 05/07/2009 | US20090117134 Truncated EGF Receptor |
| 05/07/2009 | US20090117124 Anti-IgE antibodies |
| 05/07/2009 | US20090117114 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/07/2009 | US20090117113 Immunogenic And Therapeutic Compositions For Streptococcus Pyogenes |
| 05/07/2009 | US20090117108 Gene Engineering Recombinant Anti-CEA, Anti-CD3, And Anti-CD28 Single-Chain Tri-Specific Antibody |
| 05/07/2009 | US20090117104 Glucagon-like peptide-2 (GLP-2); treating inflammatory ileus |
| 05/07/2009 | US20090117100 Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates |
| 05/07/2009 | CA2805976A1 Immunosuppressive polypeptides and nucleic acids |
| 05/07/2009 | CA2704548A1 Signal sequences and co-expressed chaperones for improving protein production in a host cell |
| 05/07/2009 | CA2703948A1 Recombinant factor viii having increased stability |
| 05/07/2009 | CA2703847A1 Methods and compositions |
| 05/06/2009 | EP2056112A1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 05/06/2009 | EP2055777A2 Methods for producing members of specific binding pairs |
| 05/06/2009 | EP2055716A1 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
| 05/06/2009 | EP2055713A1 Peptide purification by means of metal ion affinity chromatography |
| 05/06/2009 | EP2054521A2 Methods for the purification of polypeptide conjugates |
| 05/06/2009 | EP1976992A4 Methods and compositions for the detection and isolation of ligands |
| 05/06/2009 | EP1963366A4 Methods for cyclic nucleotide determination |
| 05/06/2009 | EP1774017A4 Process for improved protein expression by strain engineering |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1309336B1 Derivatives of laspartomycin and preparation and use thereof |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | EP1127142B1 Modulation of polypeptide display on modified filamentous phage |
| 05/06/2009 | EP0742824B1 Wd-40-derived peptides and uses thereof |
| 05/06/2009 | CN101426907A Cloning and expression of a novel phytase |
| 05/06/2009 | CN101426904A Cancerous disease modifying antibodies 141205-05 |
| 05/06/2009 | CN101426814A Compositions and methods for humanization and optimization of N-glycans in plants |
| 05/06/2009 | CN101426812A Methods for altering protein production rates |
| 05/06/2009 | CN101426521A EPHA2 BiTE molecules and uses thereof |
| 05/06/2009 | CN101423860A Gingeli antioxidation polypeptide composition and method for producing the same |
| 05/06/2009 | CN101423859A Method for improving protease use efficiency |
| 05/06/2009 | CN101423858A Method for preparing lipid-containing protein powder by using protease hydrolytic channel catfish ictalurus punctatus head |
| 05/06/2009 | CN101423857A Enzymatic synthesis method of Z-L-alanyl-L-glutamine |
| 05/06/2009 | CN101423856A Aminoacid polypeptide nutrient fluid, preparation method thereof and use |
| 05/06/2009 | CN101423834A Cloning and heterologous expression method of enterotoxin C2 ultra-antigen mutation protein gene |
| 05/06/2009 | CN101423553A Human monoclonal antibodies to dendritic cells |
| 05/06/2009 | CN101423551A Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded; and uses thereof |
| 05/06/2009 | CN101422204A Protein powder preparation method through hydrolyzing egg white using protease |
| 05/06/2009 | CN100485043C Fish scale collagen and its production process |
| 05/06/2009 | CN100485039C Novel bacterial phytases and method for producing same |
| 05/06/2009 | CN100485038C Miniaturized Staphylococcus aureus polypeptide of against drug-resistance and its uses and preparation method |
| 05/06/2009 | CN100485035C Novel scavenger albumen receptors |
| 05/06/2009 | CN100484956C Compound from catarrh mollase bacterial |
| 05/05/2009 | US7528245 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 05/05/2009 | US7528242 Methods and compositions comprising Renilla GFP |
| 05/05/2009 | US7528240 Method for producing human anti-thymocyte immunoglobulins |
| 05/05/2009 | US7528238 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
| 05/05/2009 | US7528235 antibodies that recognize chelating agents |
| 05/05/2009 | US7528233 covalent heterodimer of two different neurotrophins; which have multiple neurotrophic specificities; use in treatment of nervous system disorders |
| 05/05/2009 | US7527972 Uses of bispecific antibody coated dendritic cells pulsed with antigens and GM-CSF in immune regulation |
| 05/05/2009 | US7527969 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 05/05/2009 | US7527967 Recombinant baculovirus and virus-like particle |
| 05/05/2009 | US7527957 Modifying amino acid residues of the polypeptide, measuring the sensitivity of xylanase to a xylanase inhibitor, a natural inhibitor found specifically in wheat extract |
| 05/05/2009 | US7527956 modifying the C-terminal cysteine amino acid residue of human sphingomyelinase; peptide synthesis/chemical/; increase enzyme hydrolysis activity; Niemann-Pick disease, lipid histiocytosis; genetic disorder |
| 05/05/2009 | US7527952 Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA) |
| 05/05/2009 | US7527950 Ability to produce L-glutamic acid, valine, threaonine, histidine or proline is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein |
| 05/05/2009 | US7527947 Cultivating a fungal host cell comprising a nucleic acid construct comprising a first and second nucleotide sequence encoding a signal peptide; isolating the secreted polypeptide |
| 05/05/2009 | US7527946 Angiogenesis and neovascularization inhibition; host cells, recombinant DNA; increased half life and longer vasculature retention time |
| 05/05/2009 | US7527945 Producing forced open regulatory nucleotide sequence complex for use as tool in conntrolling heterologous gene expression in transfected cells |
| 05/05/2009 | US7527943 Compositions of orthogonal glutamyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 05/05/2009 | US7527942 Nucleotide sequence encoding a chimeric transactivator operably linked to the tissue-specific promoter sequence, wherein the encoded transactivator comprises a GAL4 DNA binding domain and two to four copies of a VP16 viral transcription activation domain; gene expression cassettes and vectors |
| 05/05/2009 | US7527939 Using immunoglobulins specific for brain natriuretic peptide to diagnose, classify, stratify and prognose mortality rates in patients with congestive heart failure; using biotin detector and peroxidase-labeled streptavidin reporter |
| 05/05/2009 | US7527801 Norovirus and Sapovirus antigens |
| 05/05/2009 | US7527800 Influenza hemagglutinin and neuraminidase variants |
| 05/05/2009 | US7527797 Capsular polysaccharide of Vibrio cholerae O139 covalently bound with an adipic acid dihydrazide linker to a recombinant diphtheria toxin carrier protein eliciting serum vibriocidal antibodies; conjugated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), |
| 05/05/2009 | US7527791 Humanized anti-TGF-beta antibodies |
| 05/05/2009 | US7527790 Genetic engineered protein; screening, controlling gene expression |
| 05/05/2009 | US7527786 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 04/30/2009 | WO2009055760A1 Promoter detection and analysis |
| 04/30/2009 | WO2009055711A2 Anti-rsv g protein antibodies |
| 04/30/2009 | WO2009054754A1 PHINS21 RECOMBINANT PLASMID FOR ENCODING HYBRID PROTEIN WITH HUMAN PROINSULIN, AN Escherichia coli JM109/pHINS21 BACTERIA STRAIN AS A PRODUCER OF HYBRID PROTEIN WITH HUMAN PROINSULIN AND A HUMAN PROINSULIN PRODUCING METHOD |
| 04/30/2009 | WO2009054435A1 Polypeptide having enhanced effector function |
| 04/30/2009 | WO2009054433A1 Cell for use in the production of exogenous protein, and production process using the cell |
| 04/30/2009 | WO2009054226A1 Protein purification method |
| 04/30/2009 | WO2009054091A1 Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 04/30/2009 | WO2009053985A1 Methods of processing recombinant procollagen |
| 04/30/2009 | WO2009030720A3 Process for producing a recombinant protein |
| 04/30/2009 | WO2007126813A3 Cross-reactive monoclonal antibodies recognizing als family proteins |
| 04/30/2009 | WO2007103146A3 Truncated proteins as cancer markers |
| 04/30/2009 | WO2007056352A3 Compositions and methods for controlling tissue factor signaling specificity |
| 04/30/2009 | WO2007005912A3 Compositions for treating wounds and processes for their preparation |
| 04/30/2009 | WO2006138610A3 Interferon-alpha/beta binding fusion proteins and therapeutic uses thereof |